MVT awarded Phase I SBIR grant from the NCI
- MVT
- Nov 21, 2022
- 0 min read
top of page
Search
Recent Posts
See AllMay 14th, 2025 Salt Lake City, Utah: Microvascular Therapeutics, Inc. (MVT), a biotechnology company, announced that it has completed...
Tucson, AZ & Mountain View, CA – Microvascular Therapeutics (MVT), a pioneering healthcare research and development company, is pleased...
Microvascular Therapeutics, Inc. (MVT), and SoundJet Medical, Inc. (SoundJet) announce that they have entered into a strategic...
bottom of page
コメント